Viewing Study NCT05284994


Ignite Creation Date: 2025-12-25 @ 1:28 AM
Ignite Modification Date: 2025-12-27 @ 6:56 AM
Study NCT ID: NCT05284994
Status: UNKNOWN
Last Update Posted: 2022-03-17
First Post: 2022-03-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TQ-B3525 Tablets Combined With Osimertinib Mesylate Tablets in the Treatment of Advanced Non-Small Cell Lung Cancer
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module